Topic: biotech patent news
The setback leaves Concert committed to taking the drug forward in alopecia areata but uncertain of its future beyond the indication.
Silence Therapeutics has asked the U.K. High Court of Justice to rule on an intellectual property dispute with Alnylam and The Medicines Company.
Novartis has licensed CAR-T patents from bluebird bio and Celyad.
Shares in Editas Medicine rose 30% after the U.S. patent office sided with the Broad Institute in the legal tussle over CRISPR gene editing.